Anniina Snellman

Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative (2021)

Alzheimer's Research and Therapy

Zettergren Anne, Lord Jodie, Ashton Nicholas J, Benedet Andrea L, Karikari Thomas K, Lantero Rodriguez Juan, Snellman Anniina, Suárez-Calvet Marc, Proitsi Petroula, Zetterberg Henrik, Blennow Kaj

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy (2021)

Neurology

Grothe Michel J, Moscoso Alexis, Ashton Nicholas J, Karikari Thomas K, Lantero-Rodriguez Juan, Snellman Anniina, Zetterberg Henrik, Blennow Kaj, Schöll Michael; Alzheimer’s Disease Neuroimaging Initiative

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study (2021)

Theranostics

Chaney Aisling M, Lopez-Picon Francisco R, Serrière Sophie, Wang Rui, Bochicchio Daniela, Webb Samuel D, Vandesquille Matthias, Harte Michael K, Georgiadou Christina, Lawrence Catherine, Busson Julie, Vercouillie Johnny, Tauber Clovis, Buron Frédérick, Routier Sylvain, Reekie Tristan, Snellman Anniina, Kassiou Michael, Rokka Johanna, Davies Karen E, Rinne Juha O, Salih Dervis A, Edwards Frances A, Orton Llwyd D, Williams Stephen R, Chalon Sylvie, Boutin Hervé

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

P-tau235: a novel biomarker for staging preclinical Alzheimer's disease (2021)

EMBO Molecular Medicine

Lantero-Rodriguez Juan, Snellman Anniina, Benedet Andrea L, Milà-Alomà Marta, Camporesi Elena, Montoliu-Gaya Laia, Ashton Nicholas J, Vrillon Agathe, Karikari Thomas K, Gispert Juan Domingo, Salvadó Gemma, Shekari Mahnaz, Toomey Christina E, Lashley Tammaryn L, Zetterberg Henrik, Suárez-Calvet Marc, Brinkmalm Gunnar, Neto Pedro Rosa, Blennow Kaj

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum (2021)

Brain

Alexis Moscoso, Michel J. Grothe,1 Nicholas J. Ashton, Thomas K. Karikari, Juan Lantero Rodriguez, Anniina Snellman, Marc Suarez-Calvet, Henrik Zetterberg, Kaj Blennow, Michael Schöll

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals (2021)

Brain Communications

Lussier Firoza Z, Benedet Andréa L, Therriault Joseph, Pascoal Tharick A, Tissot Cécile, Chamoun Mira, Mathotaarachchi Sulantha, Savard Melissa, Ashton Nicholas J, Karikari Thomas K, Rodriguez Juan Lantero, Snellman Anniina, Bezgin Gleb, Kang Min Su, Fernandez Arias Jaime, Wang Yi-Ting, Gauthier Serge, Zetterberg Henrik, Blennow Kaj, Rosa-Neto Pedro; Alzheimer’s Disease Neuroimaging Initiative

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease (2021)

JAMA Neurology

Moscoso Alexis, Grothe Michel J, Ashton NicholasJ, Karikari Thomas K, Lantero Rodríguez Juan, Snellman Anniina, Suárez-Calvet Marc, Blennow Kaj, Zetterberg Henrik, Schöll Michael

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

(S)-[18F]THK5117 brain uptake is associated with Aβ plaques and MAO-B enzyme in a mouse model of Alzheimer's disease (2021)

Neuropharmacology

Alzghool Obada M, Rokka Johanna, López-Picón Francisco R, Snellman Anniina, Helin Jatta S, Okamura Nobuyuki, Solin Olof, Rinne Juha O, Haaparanta-Solin Merja

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative (2020)

Molecular Psychiatry

Karikari TK, Benedet AL, Ashton NJ, Rodriguez JL, Snellman A, Suarez-Calvet M, Saha-Chaudhuri P, Lussier F, Kvartsberg H, Rial AM, Pascoal TA, Andreasson U, Scholl M, Weiner MW, Rosa-Neto P, Trojanowski JQ, Shaw LM, Blennow K, Zetterberg H

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Effect of genotype and age on cerebral [F-18]FDG uptake varies between transgenic APP(swe)-PS1(dE9) and Tg2576 mouse models of Alzheimer's disease (2019)

Scientific Reports

Anniina Snellman, Jatta S. Takkinen, Francisco R. López-Picón, Olli Eskola, Olof Solin, Juha O. Rinne, Merja Haaparanta-Solin

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Links

Publications

Sort by:

Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative (2021)

Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy (2021)

Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study (2021)

P-tau235: a novel biomarker for staging preclinical Alzheimer's disease (2021)

Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum (2021)

Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals (2021)

Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease (2021)

(S)-[18F]THK5117 brain uptake is associated with Aβ plaques and MAO-B enzyme in a mouse model of Alzheimer's disease (2021)

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative (2020)

Effect of genotype and age on cerebral [F-18]FDG uptake varies between transgenic APP(swe)-PS1(dE9) and Tg2576 mouse models of Alzheimer's disease (2019)